stavudine - CISMeF

Preferred Label : stavudine;

MeSH definition : A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.;

MeSH synonym : 2',3' didehydro 3' deoxythymidine; d4t; 2',3'-didehydro-3'-deoxythymidine; 2',3'-didehydro-2',3'-dideoxythmidine;

CISMeF synonym : Bristol-Myers squibb brand of stavudine; Bristol-Myers brand of stavudine;

MeSH hyponym : stavudine, monosodium salt; BMY-27857; zerit; BMY 27857; BMY27857;

MeSH CAS label : thymidine, 2',3'-didehydro-3'-deoxy-;

MeSH Related Number : stavudine, monosodium salt; 134624-73-0 (mono-Na salt); 3056-17-5 (Stavudine);

Registry Number MeSH : 3056-17-5;

Related CAS MeSH : 134624-73-0 (Stavudine, monosodium salt);

MeSH annotation : DF: note short X ref;

Wikipedia link : https://en.wikipedia.org/wiki/Stavudine;

Is substance : O;

UNII : BO9LE4QFZF;

InChIKey : XNKLLVCARDGLGL-JGVFFNPUSA-N;

Details

Origin ID

D018119;

UMLS CUI

C0164662;

ATC code(s)
- stavudine [ATC Code]
- stavudine and lamivudine [ATC Code]
- stavudine, lamivudine and nevirapine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Stavudine [LOINC component]
- Stavudine [ICD-11 Extension code]
- Stavudine [SMS substance]
- Stavudine [NCIt concept]
- Stavudine (substance) [SNOMED CT concept]
Pharmacological action(s)
- anti-hiv agents [MeSH Descriptor]
- antimetabolites [MeSH Descriptor]
- reverse transcriptase inhibitors [MeSH Descriptor]
Record concept(s)
- BMY-27857 [MeSH concept]
- stavudine [MeSH concept]
- stavudine, monosodium salt [MeSH concept]
- zerit [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine [MeSH Supplementary Concept]
- 2',3'-dideoxy-2',3'-didehydrothymidine monophosphate [MeSH Supplementary Concept]
- 3'-deoxythymidin-3'-yl methyl disulfide [MeSH Supplementary Concept]
- 4'-cyano-2',3'-didehydro-2',3'-dideoxythymidine [MeSH Supplementary Concept]
- 4'-cyano-2',3'-didehydro-3'-deoxythymidine [MeSH Supplementary Concept]
- 4'-ethynylstavudine [MeSH Supplementary Concept]
- 5-diacetoxymethyl-cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine [MeSH Supplementary Concept]
- 5-hydroxy-5,6-dihydrothymidine-6-phosphate [MeSH Supplementary Concept]
- Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate [MeSH Supplementary Concept]
- chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate [MeSH Supplementary Concept]
- stampidine [MeSH Supplementary Concept]
- stavudine triphosphate [MeSH Supplementary Concept]
- stavudine, lamivudine, nevirapine drug combination [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing stavudine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing stavudine (medicinal product) [SNOMED CT concept]
- Stavudine [NCIt concept]
- Stavudine [LOINC component]
- Stavudine (substance) [SNOMED CT concept]
- stavudine [ATC Code]
Validated automatic mappings to BTNT
- stavudine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients